Compare Johnson & Johnson (JNJ) vs NICE Ltd (NICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs NICE Ltd — how do they compare? Johnson & Johnson trades at $259 (market cap $626.09B), while NICE Ltd trades at $99.78 (market cap $6.02B). The key difference: Johnson & Johnson is far larger — about 104× NICE Ltd's market cap, and Johnson & Johnson pays a 2.06% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| JNJ | NICE | |
|---|---|---|
Market Cap | $626.09B | $6.02B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $153.44 |
52-Week Low | $172.78 | $83.15 |
Enterprise Value | $654.37B | $5.75B |
Dividend Yield | 2.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →
